Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00352846 · ClinicalTrials.gov registry record · Phase 3
Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss
A Phase 3 study of Lymphoma and Non-Hodgkin's Lymphoma, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 135
- Enrollment target
- 1
- Study location
NCT00352846 is a Phase 3 study of Lymphoma and Non-Hodgkin's Lymphoma that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 135 participants, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00352846, a Phase 3 study of Lymphoma and Non-Hodgkin's Lymphoma, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 135 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Objective: * Evaluate the effect of zoledronate on change in bone mineral density (BMD) at the total lumbar spine and femoral neck. Secondary Objectives: * Evaluate the effect of zoledronate on change in BMD at the total hip * Evaluate risk factors for developing osteoporosis on chemotherapy * Determine correlative markers for response to zoledronate 4. Evaluate zoledronate effect on new bone fractures 5. Evaluate the cost-effectiveness of zoledronic acid (with calcium and vitamin D) versus standard treatment (calcium and vitamin D alone).
Conditions Studied
Interventions
- DRUG Zoledronic Acid
- DRUG Vitamin D
- DRUG Calcium Carbonate
Study Locations (1)
Texas
- UT MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2006-01 |
| Est. Completion | 2011-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00352846
The ClinicalTrials.gov registry entry for NCT00352846 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 483-participant average among 299 other Lymphoma trials with a reported enrollment target (72% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lymphoma appearing as the primary indexed condition, and to 3 interventions - of which Zoledronic Acid is the first listed.
NCT00352846 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00352846 about?
NCT00352846 is a clinical study titled "Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss". Primary Objective: * Evaluate the effect of zoledronate on change in bone mineral density (BMD) at the total lumbar spine and femoral neck. Secondary Objectives: * Evaluate the effect of zoledronate on change in BMD at the total hip * Evaluate risk factors for developing osteoporosis on chemother...
What is the current status of trial NCT00352846?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 135 participants. The study started on 2006-01. Estimated completion is 2011-09.
What conditions does trial NCT00352846 study?
This clinical trial studies the following conditions: Lymphoma, Non-Hodgkin's Lymphoma.
What interventions are being tested in trial NCT00352846?
The interventions under investigation include: Zoledronic Acid (DRUG), Vitamin D (DRUG), Calcium Carbonate (DRUG).
Who is sponsoring clinical trial NCT00352846?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00352846 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
RECRUITING · Phase 3
-
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
-
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
ACTIVE NOT RECRUITING · Phase 3
-
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
ACTIVE NOT RECRUITING · Phase 3
-
Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.